Antimalarials

Name
Antimalarials
Accession Number
DBCAT000524
Description

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

Drugs
DrugDrug Description
AcedapsoneAcedapsone is a small molecule drug. Acedapsone has a monoisotopic molecular weight of 332.08 Da.
AmodiaquineAn antimalarial drug.
ArtefenomelArtefenomel has been investigated for the treatment of Malaria.
ArtefleneArteflene is a small molecule drug. Arteflene has a monoisotopic molecular weight of 408.12 Da.
ArtemetherAn antimalarial agent used in combination with lumefantrine for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.
ArtemisininA medication indicated in the treatment of malaria.
ArtemotilArtemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria...
ArtenimolFor the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB13941.
ArterolaneArterolane is under investigation in clinical trial NCT03452475 (Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+mefloquine Versus Artemether-lumefantrine in Kenyan Children).
ArtesunateArtesunate is an artemesinin derivative indicated for the initial treatment of severe malaria.
AtovaquoneAn antimicrobial indicated for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP) and for the prevention and treatment of Plasmodium falciparum malaria.
Betulinic AcidBetulinic Acid has been used in trials studying the treatment of Dysplastic Nevus Syndrome.
ChloroquineAn antimalarial drug used to treat susceptible infections with P. vivax, P. malariae, P. ovale, and P. falciparum. It is also used for second line treatment for rheumatoid arthritis.
ChlorproguanilChlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
CycloguanilCycloguanil is the active metabolite of proguanil.
DapsoneA sulfone drug used to treat acne vulgaris, Hansen's disease, and dermatitis herpetiformis.
HalofantrineAn antimalarial used for the treatment of severe malaria.
HydroxychloroquineAn antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus.
JPC-3210JPC-3210 is a potent antimalarial agent. It is an erythrocytic schizonticide with potent in vitro antimalarial activity against multidrug-resistant Plasmodium falciparum lines, low cytotoxicity, potent in vivo efficacy against murine...
LumefantrineAn antimalarial agent used in combination with artemether for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.
MefloquineAn antimalarial agent used in the prophylaxis and treatment of malaria caused by Plasmodium falciparum and Plasmodium vivax.
MizoribineMizoribine has been investigated for the treatment of Rheumatoid Arthritis.
NaphthoquineNaphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).
PepstatinPepstatin is a small molecule drug. Pepstatin has a monoisotopic molecular weight of 685.46 Da.
PiperaquineFor the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638.
PrimaquineAn antimalarial indicated to prevent relapse of vivax malaria.
ProguanilA medication indicated for prophylaxis and treatment of Plasmodium falciparum malaria.
PyrimethamineAn antiparasitic drug used in the prevention and treatment of toxoplasmosis and malaria.
PyronaridineA benzonaphthyridine derivative indicated in the treatment of acute malaria caused by P. falciparum or P. vivax in area with low rates of infection and low resistance to artemisinin.
QuinacrineFor the treatment of giardiasis and cutaneous leishmaniasis and the management of malignant effusions.
QuinidineA medication used to restore normal sinus rhythm, treat atrial fibrillation and flutter, and treat ventricular arrhythmias.
QuinineAn alkaloid used to treat uncomplicated Plasmodium falciparum malaria.
SpirogermaniumSpirogermanium is a small molecule drug. Spirogermanium has a monoisotopic molecular weight of 342.21 Da.
SulfadoxineA long acting sulfonamide used for the treatment or prevention of malaria.
TafenoquineAn antiparasitic agent used for the treatment and prevention of relapse of Vivax malaria.
TetrandrineNot Annotated